Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Galdiero
Observed names:
Galdiero Francesca,
Galdiero, Francesca
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0000-0001-7682-5381
Observed ORCID:
0000-0001-7682-5381
OpenAlex ID:
A5065259874
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
2008
·
Gennaro Chiappetta
, Angelo Ferraro
, et al.
·
European Journal of Cancer
·
72
HMGA1 protein expression in familial breast carcinoma patients
2009
·
Gennaro Chiappetta
, Alessandro Ottaiano
, et al.
·
European Journal of Cancer
·
23
Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer
2015
·
Francesca Galdiero
, Annunciata Romano
, et al.
·
Oncotarget
·
22
PDF
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience
2020
·
Daniela Califano
, Daniela Russo
, et al.
·
Cells
·
15
PDF
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients
2022
·
Crescenzo D’Alterio
, Anna Spina
, et al.
·
Cancers
·
13
PDF
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
2024
·
Daniela Russo
, Anna Spina
, et al.
·
PLoS ONE
·
6
PDF
Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysis
2018
·
Francesca Galdiero
, Anna Maria Bello
, et al.
·
Oncotarget
·
5
PDF
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells
2026
·
Federica Auletta
, Caterina Ieranò
, et al.
·
Cell Death Discovery
·
1
PDF
Dataset related to article: "Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial"
2026
·
Paracchini, Lara
, Velle, Angelo
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Abstract 7655: The CXCR4/CXCR7/CXCL12 axis and PBRM1 are involved in everolimus resistance in human renal cancer cell lines
2024
·
Federica Auletta
, Caterina Ieranò
, et al.
·
Cancer Research
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
2023
·
Russo Daniela
, Spina Anna
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Biological role of tumor/stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 advanced ovarian cancer patients
2022
·
D'Alterio, Crescenzo
, Spina, Anna
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
12
Citation count:
157
H-index:
6
I10-index:
5
Year
Topic
Type